Saturday, October 3, 2026

EUR/CHF Went Down By Over 1% In The Last 10 Sessions

EUR/CHF Went Down By Over 1% In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.09% for the last 10 sessions. At 08:19 EST on Sunday, 14 May, EUR/CHF (EURCHF) is $0.97.

EUR/CHF's yearly highs and lows, it's 3.33% up from its 52-week low and 7.307% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy fades bounce off weekly low around mid-134.00s amid downbeat yields, mixed mood. According to FXStreet on Friday, 12 May, "Looking forward, USD/JPY pair traders should pay attention to the risk catalyst for intraday directions. ", "It's worth noting, though, that the Bank of Japan's (BoJ) defense for the easy monetary policy and the US Dollar's latest recovery teases the USD/JPY buyers of late."
  • Usd/jpy struggles for a firm intraday direction, stuck in a range around mid-134.00s. According to FXStreet on Friday, 12 May, "This, along with a more dovish stance adopted by the Bank of Japan (BoJ), should hold back traders from placing aggressive bearish bets around the USD/JPY pair.", "The USD/JPY pair struggles to capitalize on the overnight bounce from the 133.75 area, or a one-week low and oscillates in a narrow trading band through the Asian session on Friday. "
  • Usd/jpy sticks to modest gains, remains below 135.00 amid subdued USD price action. According to FXStreet on Friday, 12 May, "A generally positive tone around the equity markets, along with the Bank of Japan's (BoJ) dovish outlook, undermines the safe-haven Japanese Yen (JPY) and turns out to be a key factor acting as a tailwind for the USD/JPY pair. ", "The USD/JPY pair builds on the overnight goodish rebound from the 133.75 region, or a one-week low. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com